Recordati stock edges lower as takeover offer progresses

Published on 09/19/2026 at 11:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Recordati stock closed at EUR 52.70 on September 18, 2026, slightly below recent levels as the ongoing takeover offer reaches 49.6 percent of shares tendered. The offer period runs until October 15, 2026, giving investors more time to decide.

Moderne Pharma-Produktionsanlage mit Edelstahltanks und Glasfassade bei Tageslicht — Recordati S.p.A. (IT0003828271) betreibt moderne Pharma-Produktionsanlagen mit hochwertiger Fertigungstechnik am Firmensitz in Mailand, Italien, Illustration mit AI erstellt.

Recordati stock (ISIN IT0003828271) closed at 52.70 euros on the FTSE MIB on September 18, 2026, a marginal decline of 0.09 percent from the previous session, while the company remains in the spotlight due to a progressing takeover offer.

Takeover offer reaches nearly half of Recordati shares

According to Teleborsa on September 18, 2026, the ongoing takeover offer for Recordati has reached 49.6 percent of the company’s share capital, marking a significant step toward potential change of control.

As Teleborsa reports, the offer period started on August 31, 2026 and is scheduled to end on October 15, 2026, giving shareholders several more weeks to decide whether to tender their shares at the proposed price.

Stock level, market capitalization and investor perspective

The latest FTSE MIB daily performance table shows Recordati Ord at a last value of 52.70 euros on September 18, 2026, with the same level recorded at the reference time and a daily change of minus 0.09 percent, indicating that the stock is holding close to recent trading levels despite broader market weakness.Borsa Italiana

A capitalisation ranking from Piazza Affari lists Recordati with a market capitalization of 10,832 million euros, placing the pharmaceutical group among the larger Italian blue chips and underlining the scale of the transaction implied by the takeover offer.Il Sole 24 Ore